FDA Advisory Committee Votes in Support of Approval for Pfizer's Vaccine Candidate to Help Prevent RSV in Infants Through Maternal Immunization

Amyris signs exclusive license agreement with Croda International for sustainable squalene supply

NYBC Ventures Launches Fund with USD 50m from New York Blood Center

Lumen Bioscience receives US Department of Defense project fund to develop countermeasure against respiratory viruses

Codagenix commences dosing in CodaVax-RSV paediatric Phase one study

Sinovac's CoronaVac addresses Hong Kong's need for self-pay COVID-19 vaccines

Appili Therapeutics Secures Contract for ATI-1701 Funding from the US Air Force Academy

GSK receives FDA approval for world-first RSV vaccine for older adults

GlaxoSmithKline Biologicals' Arexvy receives US FDA approval

P95 BV announces majority recapitalisation by Ampersand Capital Partners

Pfizer declares results for first-quarter 2023

Pfizer's PREVNAR 20 vaccine receives FDA approval for children, offering protection against antibiotic-resistant pneumococcal disease

BioCina receives grant for development of enabling technologies for production of precision mRNA vaccines

Orbital Therapeutics Closes USD 270m in Series A Financing

InSilicoTrials enters into strategic alliance with AchilleS Vaccines